Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5698614 | Clinical Oncology | 2012 | 8 Pages |
Abstract
There is minimal benefit to routine adaptive replanning in unselected patients, and no benefit in adjuvantly treated patients. Patients with nasopharyngeal carcinoma or with greater weight loss or reduction in neck separation did have clinically significant benefits. These patients should be targeted for adaptive strategies.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
L. Capelle, M. Mackenzie, C. Field, M. Parliament, S. Ghosh, R. Scrimger,